Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 8;20:1533033821990007. doi: 10.1177/1533033821990007

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Expression of FGD5-AS1 was up-regulated in NSCLC tissues and cells.A. qRT-PCR was employed for quantifying the expression of FGD5-AS1 in NSCLC tissues and adjacent normal tissues.B. Expression of FGD5-AS1 in BEAS-2B cells and NSCLC cells (H1650, SPC-A-1, H1299 and A549) was detected by qRT-PCR.C and D. The expression of FGD5-AS1 in NSCLC patients with different tumor size (C) and different lymph node status (D) was detected by qRT-PCR.Log-rank test was used to analyze the correlation between the expression of FGD5-AS1 and the prognosis of NSCLC patients (n = 18 in high FGD5-AS1 expression group; n = 17 in low FGD5 expression group).*P < 0.05, ***P < 0.001.